Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

NMT Medical

NMT Medical – Bringing closure to cardiac sources of stroke NMT Medical, Inc. is a publicly traded company (Nasdaq symbol NMTI), based in Boston, Massachusetts, that designs, develops, and markets innovative medical devices for the minimally invasive (non-surgical) treatment of patients who have cardiac sources of embolic stroke. Worldwide, approximately 500,000 people every year suffer an embolic stroke due to a condition called patent foramen ovale (PFO). It is estimated that PFO occurs in approximately 25% of the population. NMT’s PFO closure products are designed to treat patients who have experienced PFO-induced stroke and live in fear of another. The traditional therapy for embolic stroke is lifelong anticoagulation drug regimens. These regimens impose significant lifestyle restrictions on patients, often have side effects and rely heavily on individual patient compliance - which is not practical or achievable in all cases. Should the regimen not be effective, a further stroke could occur at any time. The societal costs of stroke disability are well documented - the personal costs immeasurable. With NMT’s products, non-surgical, catheter-based closure of the PFO can usually be achieved in less than an hour. This therapy offers peace of mind for the patient and lasts a lifetime. NMT recently embarked on a 1600 patient randomized, controlled clinical trial, called CLOSURE I, designed to evaluate the effectiveness of transcatheter PFO closure using the company's proprietary STARFlex® cardiac septal repair implant compared to best medical therapy. NMT Medical was the first company to gain regulatory approvals in the United States and Europe for devices to be used for the non-surgical closure of the PFO. Our leadership in PFO closure is further demonstrated by the length of our experience and the number of implants in this application. More than 20,000 PFO procedures have been performed worldwide.


Contact Details:
27 Wormwood St
Boston
Massachusetts
02210
United States of America
Tel:(617)737-0930
Fax:617.737.0924
Email:info@nmtmedical.com
WWW:

www.nmtmedical.com/




Loading...

Press Releases on NMT Medical:

BioPortfolio Logo
Tepha Partner Launches Novel Monofilament Absorbable Suture Utilizing Tepha's Proprietary Biomaterial 1st May, 2009 Tepha, Inc.
Tepha Corporate Partner, Aesculap AG, Introduces MonoMax(R) Monofilament Suture at the German Surgical Congress in Munich following Receipt of CE Mark LEXINGTON, Mass., May 1 /PRNewswire/ -- Tepha,
Tepha Announces Appointment of John Hartnett as Executive Vice President and Chief Operating Officer 24th July, 2008 Tepha, Inc.
LEXINGTON, Mass., July 24 /PRNewswire/ -- Tepha, Inc., a developer of medical devices derived from a new class of resorbable polymers, announced today that it has appointed John Hartnett to the

BioNews Results for NMT Medical:

Bruker Corporation Appoints William J. Knight to Chief Operating Officer and Brian P. Monahan to Chief Financial Officer
Yahoo! Canada:  Nov 9 2009 12:56PM Matching: nmt medical
SKTO '? SK3 Group, Inc. 'LATEST NEWS!! SK3 Group Signs Joint Venture With Chiropractic USA Inc.' Our Subscribe
Pharmacy Choice:  Oct 30 2009 1:43AM Matching: nmt medical
NMT Medical reports financial results for third-quarter 2009; narrows net loss to $0.22 per share
News-Medical.Net:  Oct 29 2009 12:31PM Matching: nmt medical
NMT Medical Announces Third-Quarter 2009 Financial Results
Genetic Engineering News:  Oct 29 2009 1:34PM Matching: nmt medical
NMT Medical Announces Third-Quarter 2009 Financial Results
Yahoo! Canada:  Oct 29 2009 2:14PM Matching: nmt medical
Promote your company here: BioNewsCast - Press Release Distribution

View more NMT Medical news.

NMT Medical Patents:

US Patent No.Title
7473266 Collet-based delivery system
6936058 Over-the-wire interlock attachment/detachment mechanism
6939361 Guidewire for a free standing intervascular device having an integral stop mechanism
7220265 Patent foramen ovale (PFO) closure method and device
7226466 Flexible delivery system

View more NMT Medical patents.

NMT Medical (NMTI) Financial information Links from Barchart

NMTI Quote from from Barchart.com
NMTI Chart from from Barchart.com
NMTI Profile from from Barchart.com
NMTI Opinion from from Barchart.com

View more NMT Medical finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 362 times since April 2007, the link to the organisation's website has been followed 41 times

Search for more companies in Boston

Search for more companies in Massachusetts



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for NMT Medical

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.